Ahmed Elzoghby

Cytowane przez

	Wszystkie	Od 2020
Cytowania	8858	5458
h-indeks	46	40
i10-indeks	82	76

1200

600

300

900

2012201320142015201620172018201920202021202220232024202553 152 228 354 402 544 757 838 866 1120 1106 1098 1080 175

Współautorzy

Maged Wasfy HelmyFaculty of Pharmacy, Damanhour University, Egypt.Zweryfikowany adres z pharm.dmu.edu.eg
Kadria ElkhodairyProfessor of Industrial Pharmacy, Alexandria UniversityZweryfikowany adres z alexu.edu.eg
Sherine KhattabProfessor of Organic Chemistry, Alexandria UniversityZweryfikowany adres z alexu.edu.eg
Jia-You FangChang Gung UniversityZweryfikowany adres z mail.cgu.edu.tw
May FreagLecturer of Pharmaceutics, Alexandria University Scientist at Takeda. Fellow, Harvard MSZweryfikowany adres z alexu.edu.eg
Adnan A. BekhitProfessor of Pharmacy, University of BahrainZweryfikowany adres z uob.edu.bh
Mohamed TelebAlexandria University and South Dakota State universityZweryfikowany adres z alexu.edu.eg
Mona A. Abdelmoneem AbdelwahabFaculty of Engineering, Monash UniversityZweryfikowany adres z monash.edu
Hadeer M. AbdelazizCancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria UniversityZweryfikowany adres z pharm.dmu.edu.eg
Mahmoud M. Abd ElwakilStanford UniversityZweryfikowany adres z stanford.edu
Moustafa T MabroukBiomedical Engineering, University at Buffalo, SUNYZweryfikowany adres z buffalo.edu
Islam A. HassaninKiTZ Heidelberg, DKFZZweryfikowany adres z kitz-heidelberg.de
Maha El DemellawyProfessor of Medical Biotechology, SRTA-City, New Borg El Arab, Alexandria, egyptZweryfikowany adres z srtacity.sci.eg
Sana MortadaProfessor of Industrial Pharmacy, Alexandria UniversityZweryfikowany adres z alexu.edu.eg
amira zakyAssistant Professor of BiochemistryZweryfikowany adres z alexu.edu.eg
Mohamed GaberCancer Biology DepartmentZweryfikowany adres z wakehealth.edu
Salah A SheweitaProfessor of Biochemistry & Molecular Biology, Department of Clinical Biochemistry, Faculty ofZweryfikowany adres z alexu.edu.eg
Sally A. SabraAssistant Professor of BiotechnologyZweryfikowany adres z alexu.edu.eg
Ahmed E. NoreldinAssociate Professor of Histology and Cytology, Faculty of Veterinary Medicine, Damanhour UniversityZweryfikowany adres z damanhour.edu.eg
Mohammed Bahey-El-DinProfessor of Microbiology and Immunology, Faculty of Pharmacy, Alexandria UniversityZweryfikowany adres z alexu.edu.eg

Obserwuj

Ahmed Elzoghby

Instructor of Medicine, Harvard Medical School, Brigham & Women's Hospital, Engineering in Medicine

Zweryfikowany adres z bwh.harvard.edu - Strona główna

Immunoengineering Biomedical Engineering Cancer Nanomedicine Drug Delivery Cancer Immunotherapy


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Albumin-based nanoparticles as potential controlled release drug delivery systems AO Elzoghby, WM Samy, NA Elgindy Journal of controlled release 157 (2), 168-182, 2012	1713	2012
Protein-based nanocarriers as promising drug and gene delivery systems AO Elzoghby, WM Samy, NA Elgindy Journal of controlled release 161 (1), 38-49, 2012	941	2012
Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research AO Elzoghby Journal of Controlled Release 172 (3), 1075-1091, 2013	753	2013
Casein-based formulations as promising controlled release drug delivery systems AO Elzoghby, WSA El-Fotoh, NA Elgindy Journal of controlled release 153 (3), 206-216, 2011	561	2011
Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates HM Abdelaziz, M Gaber, MM Abd-Elwakil, MT Mabrouk, MM Elgohary, ... Journal of Controlled Release 269, 374-392, 2018	365	2018
Implications of protein-and peptide-based nanoparticles as potential vehicles for anticancer drugs AO Elzoghby, MM Elgohary, NM Kamel Advances in protein chemistry and structural biology 98, 169-221, 2015	200	2015
Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand AO Elzoghby, MA Abdelmoneem, IA Hassanin, MM Abd Elwakil, ... Biomaterials 263, 120355, 2020	172	2020
Hybrid protein-inorganic nanoparticles: from tumor-targeted drug delivery to cancer imaging AO Elzoghby, AL Hemasa, MS Freag Journal of Controlled Release 243, 303-322, 2016	168	2016
Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer SA Sabra, AO Elzoghby, SA Sheweita, M Haroun, MW Helmy, ... European Journal of Pharmaceutics and Biopharmaceutics 128, 156-169, 2018	154	2018
Albumin-based nanoparticles: A promising strategy to overcome cancer drug resistance I Hassanin, A Elzoghby Cancer drug resistance 3 (4), 930, 2020	124	2020
Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics AO Elzoghby, MW Helmy, WM Samy, NA Elgindy International journal of nanomedicine, 1721-1732, 2013	123	2013
Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride AO Elzoghby, WM Samy, NA Elgindy Pharmaceutical research 30, 512-522, 2013	117	2013
Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: challenges and outcomes M Gaber, W Medhat, M Hany, N Saher, JY Fang, A Elzoghby Journal of Controlled Release 254, 75-91, 2017	116	2017
Natural polymeric nanoparticles for brain-targeting: implications on drug and gene delivery A O Elzoghby, M M Abd-Elwakil, K Abd-Elsalam, M T Elsayed, Y Hashem, ... Current pharmaceutical design 22 (22), 3305-3323, 2016	114	2016
Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy OM Ali, AA Bekhit, SN Khattab, MW Helmy, YS Abdel-Ghany, M Teleb, ... Colloids and Surfaces B: Biointerfaces 188, 110824, 2020	104	2020
Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: Formulation, characterization, and in vivo pharmacokinetics AO Elzoghby, MW Helmy, WM Samy, NA Elgindy European Journal of Pharmaceutics and Biopharmaceutics 84 (3), 487-496, 2013	104	2013
Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma DM Kabary, MW Helmy, KA Elkhodairy, JY Fang, AO Elzoghby Colloids and Surfaces B: Biointerfaces 169, 183-194, 2018	94	2018
Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy AO Elzoghby, SA El-Lakany, MW Helmy, MM Abu-Serie, NA Elgindy Nanomedicine 12 (24), 2785-2805, 2017	91	2017
Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma MA Abdelmoneem, M Mahmoud, A Zaky, MW Helmy, M Sallam, JY Fang, ... Journal of Controlled Release 287, 78-93, 2018	85	2018
Zein-based nanocarriers as potential natural alternatives for drug and gene delivery: focus on cancer therapy A Elzoghby, M Freag, H Mamdouh, K Elkhodairy Current pharmaceutical design 23 (35), 5261-5271, 2017	85	2017

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy